U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
145891145891Atrial Fibrillation Management in Congestive Heart Failure With AblationRecruitingNo Results AvailablePersistent Atrial Fibrillation|Heart Failure|ICDDevice: ICD/CRT implant|Procedure: AF ablation|Other: Best Medical Treatmenthttps://ClinicalTrials.gov/show/NCT00652522
145892145892Journey for Control of Diabetes Study (0431-111)CompletedNo Results AvailableType 2 Diabetes MellitusBehavioral: Interactive Dialogue to Educate and Activate (IDEA)|Behavioral: Individual Education (IE)https://ClinicalTrials.gov/show/NCT00652509
145893145893Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular HypertensionCompletedNo Results AvailableGlaucoma|Ocular HypertensionDrug: Bimatoprost 0.01% ophthalmic solution|Drug: Bimatoprost 0.015% formulation 1 ophthalmic solution|Drug: Bimatoprost 0.015% formulation 2 ophthalmic solution|Drug: Bimatoprost 0.02% ophthalmic solution|Drug: Bimatoprost 0.03% ophthalmic solutionhttps://ClinicalTrials.gov/show/NCT00652496
145894145894Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular HypertensionCompletedNo Results AvailableGlaucoma|Ocular HypertensionDrug: Brimonidine ophthalmic solution 0.1%|Drug: Brimonidine ophthalmic solution 0.2%https://ClinicalTrials.gov/show/NCT00652483
145895145895A Study Comparing Two Treatments for Infants With HydrocephalusActive, not recruitingNo Results AvailableHydrocephalusProcedure: Endoscopic Third Ventriculostomy|Procedure: CSF Shunt Insertionhttps://ClinicalTrials.gov/show/NCT00652470
145896145896Study of Memantine to Treat Huntington's DiseaseRecruitingNo Results AvailableHuntington's DiseaseDrug: Memantinehttps://ClinicalTrials.gov/show/NCT00652457
145897145897Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)CompletedNo Results AvailableHypercholesterolemiaDrug: ezetimibe|Drug: simvastatin|Drug: Placebo (Unspecified)https://ClinicalTrials.gov/show/NCT00652444
145898145898Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)CompletedNo Results AvailableHypercholesterolemia|HyperlipidemiaDrug: Vytorin + Niaspan|Drug: Vytorin|Drug: Niaspanhttps://ClinicalTrials.gov/show/NCT00652431
145899145899Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance AngiographyCompletedNo Results AvailableMagnetic Resonance Angiography|Peripheral Vascular Diseases|Peripheral Arterial DiseasesDrug: Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)|Drug: Gadopentetate dimeglumine (Magnevist, BAY86-4882, SH L 451A)https://ClinicalTrials.gov/show/NCT00652418
145900145900Effect of Alcohol on Cephalic Phase Reflex and Gene ExpressionCompletedNo Results AvailableType 2 Diabetes|Inflammation|Carbohydrate&Lipid Metabolism|Oral ProcessingDietary Supplement: alcohol|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT00652405
145901145901Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEMCompletedNo Results AvailableAsthmaDrug: budesonide/formoterol|Drug: budesonide and placebohttps://ClinicalTrials.gov/show/NCT00652392
145902145902Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic PatientsCompletedNo Results AvailableAcromegaly|Insulin Resistance|Impaired Glucose ToleranceDrug: Pegvisomant|Drug: Somatostatin analog (lanreotide or octreotide)https://ClinicalTrials.gov/show/NCT00652379
145903145903A Dose-Escalation to Rash Study of Tarceva (Erlotinib) Plus Gemcitabine in Patients With Metastatic Pancreatic CancerCompletedHas ResultsPancreatic CancerDrug: Erlotinib, escalating dose|Drug: Erlotinib, standard dose|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00652366
145904145904Mnemonic for the Ottawa Ankle RuleCompletedNo Results AvailableAnkle Trauma|EducationOther: 44-55-66-PM|Other: controlhttps://ClinicalTrials.gov/show/NCT00652353
145905145905APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung CancerCompletedHas ResultsRecurrent Non Small Cell Lung CancerDrug: apricoxib/erlotinib|Drug: erlotinib/placebohttps://ClinicalTrials.gov/show/NCT00652340
145906145906Comparison of Ezetimibe Added to Ongoing Statin Therapy Versus Doubling the Dose of Statin in the Treatment of Hypercholesterolemia (P04355)CompletedHas ResultsHypercholesterolemiaDrug: Ezetimibe + Statin (simvastatin, atorvastatin, or pravastatin)|Drug: Double Statin (simvastatin, atorvastatin, or pravastatin)https://ClinicalTrials.gov/show/NCT00652327
145907145907Evaluation of an Absorbable Surgical Hemostatic Agent: Thrombi-Gel® Versus Gelfoam-ThrombinActive, not recruitingNo Results AvailableSurgical Intervention Hemostasis|Comparison of Surgical HemostatsDevice: Thrombi-Gelhttps://ClinicalTrials.gov/show/NCT00652314
145908145908A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)CompletedNo Results AvailableCholesterolDrug: ezetimibe|Drug: Comparator: Placebo (unspecified)|Drug: simvastatinhttps://ClinicalTrials.gov/show/NCT00652301
145909145909Evaluation of Pharmacokinetics and Pharmacodynamic Properties of Rapid-Acting Insulin AnalogsEnrolling by invitationNo Results AvailableDiabetes Mellitus, Type IDrug: Insulin analogs (Lispro and Aspart)https://ClinicalTrials.gov/show/NCT00652288
145910145910Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria VaccineRecruitingNo Results AvailableMalariaBiological: MSP3 Long Synthetic Peptide 30 micrograms of MSP3 LSP|Biological: Verorab vaccinehttps://ClinicalTrials.gov/show/NCT00652275
145911145911BAY38-9456 - Supportive Trial for Spinal InjuryCompletedNo Results AvailableErectile Dysfunction|Sexual Dysfunction|Spinal Cord InjuryDrug: Levitra (Vardenafil, BAY38-9456)https://ClinicalTrials.gov/show/NCT00652262
145912145912Diagnosing Malfunctioning Hydrocephalic Shunt Valves With a Flow SensorWithdrawnNo Results AvailableHydrocephalushttps://ClinicalTrials.gov/show/NCT00652249
145913145913Cost of Long Term Disability in Patients With Chronic Non-Specific Low Back PainTerminatedNo Results AvailableLow Back PainOther: Physiotherapyhttps://ClinicalTrials.gov/show/NCT00652236
145914145914Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite AllergyCompletedNo Results AvailablePerennial Allergic Rhinoconjunctivitis|Allergic AsthmaBiological: CYT005-AllQbG10https://ClinicalTrials.gov/show/NCT00652223
145915145915Use of Multiphoton Microscopy in the Diagnosis of CancerRecruitingNo Results AvailableBladder Cancer|Prostate CancerOther: Multiphoton microscopyhttps://ClinicalTrials.gov/show/NCT00652210
145916145916Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow SensorEnrolling by invitationNo Results AvailableHydrocephalushttps://ClinicalTrials.gov/show/NCT00652197
145917145917Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)Active, not recruitingNo Results AvailableHerpes Zoster|Postherpetic NeuralgiaDrug: ARYS-01 (sorivudine) cream 3% or placebo cream|Drug: placebo|Drug: valaciclovirhttps://ClinicalTrials.gov/show/NCT00652184
145918145918Efficacy and Safety of Antidepressant Augmentation With LamotrigineCompletedNo Results AvailableDepressionDrug: Lamotrigine|Dietary Supplement: Amidehttps://ClinicalTrials.gov/show/NCT00652171
145919145919A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced MalignanciesTerminatedNo Results AvailableAdvanced MalignanciesDrug: MLN8054https://ClinicalTrials.gov/show/NCT00652158
145920145920Dose Escalation and Remission (DEAR)CompletedHas ResultsUlcerative ColitisDrug: mesalaminehttps://ClinicalTrials.gov/show/NCT00652145

* Görseller ve İçerik tekif hakkına sahip olabilir